NCT00002960View on ClinicalTrials.gov

SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)

PHASE1CompletedINTERVENTIONAL

Enrollment

59

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

July 31, 2000

Study Completion Date

July 31, 2000

Conditions

Fallopian Tube CancerMetastatic CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL

recombinant adenovirus-p53 SCH-58500

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY